Question to the Home Office:

To ask the Secretary of State for the Home Department, what assessment her Department has made of trends in the level of awareness amongst police constabularies of the legislation around the use of prescribed medical cannabis.

CBPMs were placed in Schedule 2 to the Misuse of Drugs Regulations 2001 (“the 2001 Regulations’”) in 2018. This means that specialist clinicians can prescribe CBPMs where they deem it clinically appropriate and in the best interests of their patients, and patients may legally possess CBPMs when in possession of a valid UK prescription or if they are a participant in a clinical trial. Home Office Circular 018/2018, summarising the introduction of CBPMs, was published when the measures came into force.

Home Office circulars are aimed primarily at law enforcement, including the police, and are published on gov.uk. Circular 018/2018 is available at the following link: https://www.gov.uk/government/publications/circular-0182018-rescheduling-of-cannabis-based-products-for-medicinal-use-in-humans.

The Home Office liaises with the police to support awareness and understanding of drug legislation across police forces. This includes liaison through the National Police Chief’s Council

Additionally, the Home Office and the Department for Health and Social Care contributed to the guidance document “‘Medical cannabis (and cannabis oils)” , which is available on the NHS’ page on at the following link: https://www.nhs.uk/conditions/medical-cannabis/.